| scholarly article | Q13442814 |
| P2093 | author name string | Joshua A. Boyce | |
| Laura B. Fanning | |||
| P2860 | cites work | A double-blind, placebo-controlled trial of the thromboxane synthetase blocker OKY-046 on bronchial hypersensitivity in bronchial asthma patients | Q74789102 |
| Pronounced eosinophilic lung inflammation and Th2 cytokine release in human lipocalin-type prostaglandin D synthase transgenic mice | Q77373986 | ||
| Effects of thromboxane A2 antagonist on airway hyperresponsiveness, exhaled nitric oxide, and induced sputum eosinophils in asthmatics | Q77653813 | ||
| Protective effects of inhaled PGE2 on allergen-induced airway responses and airway inflammation | Q77747398 | ||
| Effect of AA-2414, a thromboxane A2 receptor antagonist, on airway inflammation in subjects with asthma | Q77846743 | ||
| Prostaglandin I2 analogs inhibit Th1 and Th2 effector cytokine production by CD4 T cells | Q79393955 | ||
| Cysteinyl leukotrienes regulate Th2 cell-dependent pulmonary inflammation | Q82879026 | ||
| Inhibition of the asthmatic allergen challenge response by the CRTH2 antagonist OC000459 | Q83866811 | ||
| Safety and efficacy of the prostaglandin D2 receptor antagonist AMG 853 in asthmatic patients | Q85510369 | ||
| Iloprost inhalation in mild asthma | Q87407109 | ||
| PGI₂ signaling inhibits antigen uptake and increases migration of immature dendritic cells | Q36935767 | ||
| Therapeutic alternatives for chronic urticaria: an evidence-based review, part 1. | Q37179168 | ||
| Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation | Q37286185 | ||
| FLAP inhibitors for the treatment of inflammatory diseases | Q37624502 | ||
| Leukotriene modifiers for asthma treatment | Q37808003 | ||
| Cysteinyl leukotriene receptors, old and new; implications for asthma | Q38038319 | ||
| Prostanoids as regulators of innate and adaptive immunity. | Q38051863 | ||
| CRTH2 antagonists in the treatment of allergic responses involving TH2 cells, basophils, and eosinophils | Q38062048 | ||
| The CRTH2 antagonist OC000459 reduces nasal and ocular symptoms in allergic subjects exposed to grass pollen, a randomised, placebo-controlled, double-blind trial | Q38463456 | ||
| A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma | Q38487823 | ||
| PGE(2) receptor (EP(4)) agonists: potent dilators of human bronchi and future asthma therapy? | Q39664542 | ||
| In vitro and in vivo effects of leukotriene B4 antagonism in a primate model of asthma | Q39758020 | ||
| Pharmacological interactions between prostacyclin and thromboxanes | Q40137633 | ||
| Effect of Oral Administration of A Prostacyclin Analog (Op-41483) On Pulmonary Function and Bronchial Responsiveness in Stable Asthmatic Subjects | Q41948877 | ||
| Pharmacokinetics and pharmacodynamics of the leukotriene B4 receptor antagonist CP-105,696 in man following single oral administration | Q42075145 | ||
| Release of prostaglandin D2 into human airways during acute antigen challenge | Q42216102 | ||
| Persistent increase in plasma and urinary leukotrienes after acute asthma | Q42375124 | ||
| Airway inflammation and responsiveness in prostaglandin H synthase-deficient mice exposed to bacterial lipopolysaccharide. | Q42512398 | ||
| Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. Zileuton Clinical Trial Group | Q42556993 | ||
| Effects of LTB4 receptor antagonism on pulmonary inflammation in rodents and non-human primates | Q43136931 | ||
| Allergen-stimulated release of thromboxane A2 and leukotriene E4 in humans. Effect of indomethacin | Q43536142 | ||
| Evidence for elevated levels of histamine, prostaglandin D2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma | Q43658945 | ||
| Effects of prednisone on the cellular responses and release of cytokines and mediators after segmental allergen challenge of asthmatic subjects | Q43669689 | ||
| Anti-eosinophil activity and clinical efficacy of the CRTH2 antagonist OC000459 in eosinophilic esophagitis | Q43686203 | ||
| A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model | Q43846995 | ||
| Selective cyclooxygenase-1 and -2 inhibitors each increase allergic inflammation and airway hyperresponsiveness in mice | Q43961084 | ||
| Bronchoconstrictor effects of leukotriene E4 in normal and asthmatic subjects | Q44241228 | ||
| Prostaglandin I2 analogs inhibit proinflammatory cytokine production and T cell stimulatory function of dendritic cells | Q44325026 | ||
| Role of prostaglandin I2 in airway remodeling induced by repeated allergen challenge in mice | Q44391228 | ||
| Leukotrienes mediate part of Ova-induced lung effects in mice via EGFR. | Q44470098 | ||
| Effects of inhaled corticosteroids on exhaled leukotrienes and prostanoids in asthmatic children | Q45103516 | ||
| Dissociation of airway inflammation and hyperresponsiveness by cyclooxygenase inhibition in allergen challenged mice | Q46104730 | ||
| Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3. | Q46418233 | ||
| Augmentation of allergic inflammation in the airways of cyclooxygenase-2-deficient mice | Q46432048 | ||
| Prostaglandin E2 protects lower airways against bronchoconstriction | Q46661216 | ||
| Prostaglandin D2 inhibits airway dendritic cell migration and function in steady state conditions by selective activation of the D prostanoid receptor 1. | Q47581798 | ||
| Absence of leukotriene B4 receptor 1 confers resistance to airway hyperresponsiveness and Th2-type immune responses | Q47724295 | ||
| Accentuated T helper type 2 airway response after allergen challenge in cyclooxygenase-1-/- but not cyclooxygenase-2-/- mice. | Q51683175 | ||
| EP(2) receptor mediates bronchodilation by PGE(2) in mice. | Q52539531 | ||
| A novel prostacyclin agonist protects against airway hyperresponsiveness and remodeling in mice. | Q53180552 | ||
| E prostanoid 2 (EP2)/EP4-mediated suppression of antigen-specific human T-cell responses by prostaglandin E2. | Q54593169 | ||
| Induced Sputum Eicosanoid Concentrations in Asthma | Q55094021 | ||
| The Pivotal Role of 5-Lipoxygenase Products in the Reaction of Aspirin-sensitive Asthmatics to Aspirin | Q57240791 | ||
| Effect of Inhaled Prostaglandin E2on Allergen-induced Asthma | Q57415843 | ||
| Inflammatory mediator release on conjunctival provocation of allergic subjects with allergen | Q67657662 | ||
| Urinary Leukotriene E4Concentrations Increase after Aspirin Challenge in Aspirin-sensitive Asthmatic Subjects | Q67915846 | ||
| Thromboxane A2 biosynthesis in acute asthma and after antigen challenge | Q68181110 | ||
| Two thromboxane A2 receptor isoforms in human platelets. Opposite coupling to adenylyl cyclase with different sensitivity to Arg60 to Leu mutation | Q24562692 | ||
| Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes | Q24633568 | ||
| Why there are two cyclooxygenase isozymes | Q27863307 | ||
| BLT1 and BLT2: the leukotriene B(4) receptors | Q28191625 | ||
| Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis | Q28194143 | ||
| Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis | Q28219122 | ||
| Activation of the prostaglandin D2 receptor DP2/CRTH2 increases allergic inflammation in mouse | Q28238317 | ||
| Regulating leukotriene synthesis: the role of nuclear 5-lipoxygenase | Q28276459 | ||
| Identification of GPR99 protein as a potential third cysteinyl leukotriene receptor with a preference for leukotriene E4 ligand | Q28287399 | ||
| The Leukotrienes: Immune-Modulating Lipid Mediators of Disease | Q29036681 | ||
| Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation | Q30442280 | ||
| Prostanoid receptors: subtypes and signaling | Q34192781 | ||
| Phospholipase A(2). | Q34219384 | ||
| Cloning and Characterization of the Human Leukotriene A4 Hydrolase Gene | Q34301660 | ||
| The phospholipase A2 superfamily and its group numbering system | Q34566140 | ||
| CysLT2 receptors interact with CysLT1 receptors and down-modulate cysteinyl leukotriene dependent mitogenic responses of mast cells | Q34662206 | ||
| Dectin-2 mediates Th2 immunity through the generation of cysteinyl leukotrienes | Q34681509 | ||
| Augmentation of allergic inflammation in prostanoid IP receptor deficient mice | Q35044600 | ||
| Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation | Q35545787 | ||
| EP4 receptor as a new target for bronchodilator therapy | Q35564982 | ||
| Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradation | Q35660728 | ||
| Antagonism of the prostaglandin D2 receptor CRTH2 attenuates asthma pathology in mouse eosinophilic airway inflammation | Q35663953 | ||
| Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic | Q35760394 | ||
| Cysteinyl leukotrienes and their receptors: cellular distribution and function in immune and inflammatory responses | Q35841909 | ||
| T-cell trafficking in asthma: lipid mediators grease the way. | Q35877210 | ||
| Prostaglandin E2 deficiency uncovers a dominant role for thromboxane A2 in house dust mite-induced allergic pulmonary inflammation | Q36140425 | ||
| Activation of the D prostanoid 1 receptor suppresses asthma by modulation of lung dendritic cell function and induction of regulatory T cells | Q36229711 | ||
| Cysteinyl leukotriene 2 receptor on dendritic cells negatively regulates ligand-dependent allergic pulmonary inflammation | Q36339008 | ||
| The importance of leukotrienes in airway inflammation in a mouse model of asthma | Q36367477 | ||
| Prostaglandin D2 reinforces Th2 type inflammatory responses of airways to low-dose antigen through bronchial expression of macrophage-derived chemokine | Q36371613 | ||
| Cyclooxygenase-1 overexpression decreases Basal airway responsiveness but not allergic inflammation | Q36420377 | ||
| Pulmonary responses to bronchoconstrictor agonists in the mouse | Q69034596 | ||
| Effect of indomethacin on allergen-induced asthmatic responses | Q69190652 | ||
| Thromboxane biosynthesis in allergen-induced bronchospasm. Evidence for platelet activation | Q69240613 | ||
| The major source of endogenous prostaglandin D2 production is likely antigen-presenting cells. Localization of glutathione-requiring prostaglandin D synthetase in histiocytes, dendritic, and Kupffer cells in various rat tissues | Q69244268 | ||
| Mediator release after nasal airway challenge with allergen | Q70287869 | ||
| Bronchoconstrictor effects of leukotriene C in humans | Q70298182 | ||
| Comparative bronchoconstrictor effects of histamine, leukotriene C, and leukotriene D in normal human volunteers | Q70629252 | ||
| Indomethacin modification of immediate-type immunologic airway responses in allergic asthmatic and non-asthmatic subjects: evidence for altered arachidonic acid metabolism in asthma | Q70897542 | ||
| Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma | Q70906164 | ||
| Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial. Zileuton Study Group | Q71823499 | ||
| Leukotriene C4 formation by transcellular biosynthesis | Q72029852 | ||
| Airway responsiveness to leukotriene C4 (LTC4), leukotriene E4 (LTE4) and histamine in aspirin-sensitive asthmatic subjects | Q72252746 | ||
| Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge | Q72328568 | ||
| Prostaglandin D2-induced bronchoconstriction is mediated only in part by the thromboxane prostanoid receptor | Q72332303 | ||
| Effect of inhaled PGE2 on exercise-induced bronchoconstriction in asthmatic subjects | Q72398978 | ||
| Increased Production of Prostaglandin D2 in Patients with Systemic Mastocytosis | Q72437053 | ||
| Cutting edge: differential production of prostaglandin D2 by human helper T cell subsets | Q73458387 | ||
| 5-Lipoxygenase products are necessary for ovalbumin-induced airway responsiveness in mice | Q73519746 | ||
| Cyclooxygenase inhibition increases interleukin 5 and interleukin 13 production and airway hyperresponsiveness in allergic mice | Q74139304 | ||
| Effect of thromboxane A2 inhibitors on allergic pulmonary inflammation in mice | Q74575532 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 155-62 | |
| P577 | publication date | 2013-09-01 | |
| P1433 | published in | Annals of Allergy, Asthma & Immunology | Q13429696 |
| P1476 | title | Lipid mediators and allergic diseases | |
| P478 | volume | 111 |
| Q37519095 | A TNFRSF14-FcɛRI-mast cell pathway contributes to development of multiple features of asthma pathology in mice |
| Q64102452 | Arachidonic Acid Derived Lipid Mediators Influence Kaposi's Sarcoma-Associated Herpesvirus Infection and Pathogenesis |
| Q50142752 | As You Eat It: Effects of prenatal nutrition on asthma. |
| Q40350220 | Association Between Migraine and Atopic Diseases in Childhood: A Potential Protective Role of Anti-Allergic Drugs. |
| Q26767423 | Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases |
| Q38693289 | Cytochrome P450 and Lipoxygenase Metabolites on Renal Function |
| Q89098605 | Cytokine and Lipid Mediator Regulation of Group 2 Innate Lymphoid Cells (ILC2s) in Human Allergic Airway Disease |
| Q90191790 | Gut Microbial-Derived Metabolomics of Asthma |
| Q90419317 | ILC2 Activation by Protozoan Commensal Microbes |
| Q33801028 | In vivo metabolite profiling as a means to identify uncharacterized lipase function: recent success stories within the alpha beta hydrolase domain (ABHD) enzyme family |
| Q51703960 | Induced sputum eicosanoids during aspirin bronchial challenge of asthmatic patients with aspirin hypersensitivity. |
| Q38723602 | Inhibitory Effects of Viscum coloratum Extract on IgE/Antigen-Activated Mast Cells and Mast Cell-Derived Inflammatory Mediator-Activated Chondrocytes. |
| Q33998131 | Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy |
| Q40059650 | Neutrophil-Derived Cytosolic PLA2α Contributes to Bacterial-Induced Neutrophil Transepithelial Migration. |
| Q94569758 | Peroxisome Proliferator-Activated Receptors as a Therapeutic Target in Asthma |
| Q50025252 | Prostaglandin E2 suppresses human group 2 innate lymphoid cell function. |
| Q38205153 | Re-visiting Hypersensitivity Reactions to Taxanes: A Comprehensive Review |
| Q36240870 | Sphingosine-1-phosphate and other lipid mediators generated by mast cells as critical players in allergy and mast cell function |
| Q38248535 | Targeting 5-lipoxygenase-activating protein in asthma and chronic obstructive pulmonary disease |
| Q38751729 | The Herbal Medicine KIOM-MA128 Inhibits the Antigen/IgE-Mediated Allergic Response in Vitro and in Vivo. |
| Q35691073 | The Intracellular Localisation and Phosphorylation Profile of the Human 5-Lipoxygenase Δ13 Isoform Differs from That of Its Full Length Counterpart |
| Q88003632 | The nasal microbiome in asthma |
| Q64090615 | Understanding Asthma Phenotypes, Endotypes, and Mechanisms of Disease |
Search more.